HAVCR2 and neoplasm: HMGB1 has also been reported to bind to T-cell immunoglobulin and mucin domain 3 (TIM-3) expressed by tumor-associated dendritic cells (DCs) in murine tumors and patients with cancer [11] as one of several immunosuppressive mechanisms activated by this pleotropic protein.